Turn Therapeutics
TTRX
20 hedge funds and large institutions have $1.48M invested in Turn Therapeutics in 2026 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 4 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
0.01% less ownership
Funds ownership: 1.58% → 1.57% (-0.01%)
9% less funds holding
Funds holding: 22 → 20 (-2)
20% less capital invested
Capital invested by funds: $1.84M → $1.48M (-$358K)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DI
DDFG Inc
Thousand Oaks,
California
|
+$71.1K |
| 2 |
TS
Tamar Securities
Woodland Hills,
California
|
+$58.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$1.56K |
| 4 |
LPL Financial
San Diego,
California
|
+$1.17K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$101K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$82.7K |
| 3 |
Jane Street
New York
|
-$67.6K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$21.2K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
TTRX Hedge Fund Activity: Q1 2026 in Review
20 of the 8,191 institutional investors tracked by Wall St. Rank reported a position in Turn Therapeutics (TTRX) for Q1 2026, worth a combined $1.48M — down 20% from $1.84M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of TTRX and 3 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was DDFG Inc, adding an estimated $71.1K. The largest seller was Millennium Management, cutting an estimated $101K.
- 20 institutional investors held Turn Therapeutics (TTRX) as of Q1 2026, down from 22 in Q4 2025.
- Funds reported $1.48M of Turn Therapeutics stock for Q1 2026, down 20% quarter-over-quarter.
- 3 funds opened new Turn Therapeutics positions in Q1 2026 and 4 closed out, a net change of -1 holder.
- The largest Turn Therapeutics buyer in Q1 2026 was DDFG Inc, an estimated $71.1K added.
- The largest Turn Therapeutics seller in Q1 2026 was Millennium Management, an estimated $101K sold.
Based on aggregated 13F filings for Q1 2026.